Prevention of cardiovascular disease in diabetes mellitus - clinical center network. (1999 - 2009)
Multicenter, double-blind, randomized, placebo controlled, dose ranging phase 2 study to investigate efficacy, safety, tolerability and pharmacokinetics of the DPP-IV inhibitor RO0730699 in patients with type 2 diabetes, who are treated with a stable dose of metformin. (2005)
Clinical Evaluation of the Safety and Feasibility of the Investigational BD Continuous Glucose Monitoring Sensor (2005)
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology, drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.